NCT03325101 2025-06-12Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable MelanomaMayo ClinicPhase 1/2 Terminated7 enrolled 11 charts
NCT01065441 2020-01-22Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV CancerMirror Biologics, Inc.Phase 1/2 Completed9 enrolled